Related Experiment Video
Updated: Aug 27, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
Effectiveness of CoronaVac vaccination against COVID-19 development in healthcare workers: real-life data
Betul Copur1, Serkan Surme1,2, Ugurcan Sayili3
1Department of Infectious Diseases & Clinical Microbiology, Haseki Training & Research Hospital, Istanbul, 34265, Turkey.
Abstract:
Background: This study was designed to investigate the effectiveness of CoronaVac in preventing COVID-19 in healthcare workers (HCWs) during the Alpha variant-dominant period. Materials & methods: Follow-up was initiated 14 days after the second dose for double-dose vaccinated HCWs and on 25 February 2021, for the unvaccinated group. The incidence rate ratio was calculated to estimate the unadjusted effectiveness. Cox regression was used to adjust the effectiveness of CoronaVac. Results & Conclusion: The adjusted effectiveness of CoronaVac against COVID-19 was 65% (95% CI: 50-75%). Compared with the results of the phase III trial conducted in Turkey, a lower effectiveness of CoronaVac against COVID-19 was detected in this real-life study. This finding suggests that mass vaccination and booster doses are needed.
Related Concept Videos
Antimicrobial Effectiveness
Vaccinations
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Bias in Epidemiological Studies
Secondary Healthcare System
Statistical Methods for Analyzing Epidemiological Data

